Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Shares Outstanding (Weighted Average) (2020 - 2025)

RxSight (RXST) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $40.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 5.1% year-over-year to $40.9 million, compared with a TTM value of $40.9 million through Dec 2025, up 5.1%, and an annual FY2025 reading of $40.9 million, up 5.1% over the prior year.
  • Shares Outstanding (Weighted Average) was $40.9 million for Q4 2025 at RxSight, roughly flat from $40.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $40.9 million in Q4 2025 and bottomed at $4.0 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $29.5 million, with a median of $33.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 586.3% in 2022, then increased 5.1% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $13.6 million in 2021, then soared by 103.02% to $27.7 million in 2022, then grew by 24.56% to $34.5 million in 2023, then grew by 12.81% to $38.9 million in 2024, then grew by 5.1% to $40.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RXST at $40.9 million in Q4 2025, $40.7 million in Q3 2025, and $40.7 million in Q2 2025.